Livmarli

Medicinal product

(Invented) name

Livmarli

Active substance (s)

Maraliksibatas

Strength

15 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A05AX04, maralixibat chloride

Marketing authorisation holder

Mirum Pharmaceuticals International B.V., Nyderlandai

Date of authorisation

2022-12-09

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Maraliksibatas	15 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120114	106219	1106219	buteliukas	N30		Receptinis	EU/1/22/1704/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-12-09	Registruotas